Filing Details
Vericel Corp (NASDAQ:VCEL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:VCEL
Vericel Corp (VCEL) Files Quarterly Report for Q0
Filing Details Vericel Corp (NASDAQ:VCEL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026. The Healthcare company reported Q0…
Market Context
Vericel Corp's stock currently trades at $47.61 with a market capitalization of $1.9B.
The 10-Q provides Vericel Corp's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Vericel Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VCEL Stock Page
Frequently Asked Questions
Where can I read VCEL's SEC filings?
Browse all filings on our VCEL SEC filings page.
What types of SEC filings does Vericel Corp file?
Public companies like Vericel Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Loading related coverage…